- Research works
- 74 ▼ 31% vs 2018-21
- Citations
- 2k 26.3 per fractional work
- Top-10% rate
- 6.3% all institutions 10.0%
- Open access
- 58% world 40%
- International
- 26% world 18%
Not ranked overall: PhoenixBio (Japan) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does PhoenixBio (Japan) work in?
In all years, 58% of research at PhoenixBio (Japan) is in Health Sciences, 38% in Life Sciences. Its largest fields are Medicine (57%), Biochemistry, Genetics and Molecular Biology (20%), Pharmacology, Toxicology and Pharmaceutics (10%). It does 2.3× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 14 fields, with their numbers
- Health Sciences4358.0%
- Medicine4357.5%
- Nursing00.4%
- Veterinary00.1%
- Life Sciences2837.7%
- Physical Sciences33.4%
- Engineering11.9%
- Materials Science11.1%
- Computer Science00.3%
- Mathematics00.1%
- Social Sciences10.9%
- Psychology10.8%
- Decision Sciences00.1%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 18.5×. Every wedge is a field page.
All 10 fields, with their numbers
- Pharmacology, Toxicology and Pharmaceutics18.47×1 works
- Immunology and Microbiology4.69×1 works
- Biochemistry, Genetics and Molecular Biology3.91×2 works
- Nursing3.72×0 works
- Neuroscience2.73×0 works
- Medicine2.73×6 works
- Decision Sciences0.94×0 works
- Agricultural and Biological Sciences0.92×0 works
- Engineering0.23×0 works
- Materials Science0.13×0 works
Who are the top researchers at PhoenixBio (Japan)?
Ranked on the quality score, Akira Shiota, Yuji Ishida and Mutsumi Inamatsu lead among researchers whose main affiliation is PhoenixBio (Japan).
- 1
Akira Shiota
Japan · #2,226,890 worldwide 1.3k citations · 43 works
- 2
Yuji Ishida
Japan · #2,413,619 worldwide 3.9k citations · 220 works
- 3
Mutsumi Inamatsu
Japan · #2,584,810 worldwide 535 citations · 24 works
- 4
Chise Tateno
Japan · #2,943,345 worldwide 6k citations · 210 works
- 5
Masakazu Kakuni
Japan · #3,758,974 worldwide 855 citations · 48 works
Which keywords describe research at PhoenixBio (Japan)?
By fractional works in all years, weighted toward what it does more of than the world: Oxidative Stress, Hepatocellular Carcinoma, Inflammation, Metabolic Syndrome, Immune Response, Genetic Variation, Liver Disease and Antiviral Therapy.
- Antioxidants
- Apoptosis
- ß-Cell Dysfunction
- Hepatotoxicity
- Hepatitis C Virus
- Multidrug Resistance
- ATP-dependent Transporters
- Metabolic Regulation
- Global Burden
- Cancer
- Pharmacogenetics
- Pharmacokinetics
- Liver Regeneration
- Macrophages
- NAFLD
- Hepatic Steatosis
- Liver Disease
- Genetic Variation
- Metabolic Syndrome
- Inflammation
- Oxidative Stress
- Hepatocellular Carcinoma
- Immune Response
- Antiviral Therapy
- Insulin Resistance
- Angiogenesis
- NASH
- Hepatic Stellate Cells
- Cytochrome P450
- Drug Metabolism
- Nuclear Receptors
- Chronic Hepatitis B
- Hepatitis B Virus
- Treatment
- Liver Transplantation
- Biomarkers
- Ribavirin
- Pancreatic Islets
- Mitochondrial Dysfunction
- Acetaminophen
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Oxidative Stress14▲ 9.9×11 topics
- Inflammation11▲ 6.1×23 topics
- Hepatocellular Carcinoma10▲ 63×3 topics
- Metabolic Syndrome9▲ 14×7 topics
- Immune Response9▲ 19×10 topics
- Genetic Variation8▲ 35×3 topics
- Antiviral Therapy8▲ 67×3 topics
- Liver Disease8▲ 74×3 topics
- Insulin Resistance7▲ 21×5 topics
- Hepatic Steatosis6▲ 58×2 topics
- Angiogenesis6▲ 20×6 topics
- NAFLD6▲ 71×1 topic
- NASH6▲ 71×1 topic
- Macrophages6▲ 47×2 topics
- Hepatic Stellate Cells6▲ 300×1 topic
- Liver Regeneration6▲ 300×1 topic
- Cytochrome P4505▲ 93×2 topics
- Pharmacokinetics5▲ 24×3 topics
- Drug Metabolism5▲ 114×1 topic
- Pharmacogenetics5▲ 158×1 topic
- Nuclear Receptors4▲ 33×4 topics
- Cancer4▲ 4.0×22 topics
- Chronic Hepatitis B4▲ 105×1 topic
- Global Burden4▲ 10×2 topics
- Hepatitis B Virus4▲ 105×1 topic
- Metabolic Regulation4▲ 19×4 topics
- Treatment4▲ 4.0×5 topics
- ATP-dependent Transporters4▲ 95×1 topic
- Liver Transplantation4▲ 32×4 topics
- Multidrug Resistance4▲ 82×1 topic
- Biomarkers4▲ 7.8×5 topics
- Hepatitis C Virus3▲ 88×1 topic
- Ribavirin3▲ 88×1 topic
- Hepatotoxicity3▲ 61×2 topics
- Pancreatic Islets3▲ 67×1 topic
- ß-Cell Dysfunction3▲ 67×1 topic
- Mitochondrial Dysfunction3▲ 10×4 topics
- Apoptosis3▲ 8.8×8 topics
- Acetaminophen2▲ 99×1 topic
- Antioxidants2▲ 7.6×2 topics
Which research topics does PhoenixBio (Japan) publish most on?
By volume in 2022-now: Liver physiology and pathology, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies and Hepatitis C virus research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Liver physiology and pathology Hepatology 1 works
- 2 Liver Disease Diagnosis and Treatment Epidemiology 1 works
- 3 Hepatitis B Virus Studies Epidemiology 1 works
- 4 Hepatitis C virus research Hepatology 0 works
- 5 Pharmacogenetics and Drug Metabolism Pharmacology 0 works
- 6 Pancreatic function and diabetes Surgery 0 works
- 7 Metabolism and Genetic Disorders Clinical Biochemistry 0 works
- 8 Genomics and Phylogenetic Studies Molecular Biology 0 works
- 9 Image Processing Techniques and Applications Media Technology 0 works
- 10 Cell Image Analysis Techniques Biophysics 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has PhoenixBio (Japan)'s research output changed?
Output in 2022-2025 was 31% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is PhoenixBio (Japan) as a percentage of every work published that year, 0.000045% in 2024.
Fractional works of PhoenixBio (Japan) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Hiroshima
- Hiroshima University
- Hiroshima City University
- Hiroshima Institute of Technology
- Prefectural University of Hiroshima
- Hiroshima University of Economics
- Hiroshima City Asa Citizens Hospital
- Mazda Motor Corporation (Japan)
- Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about PhoenixBio (Japan). Posts are plain text and can be reported.